skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Everyone at 5i! You have mentioned that HHL is not your favorite ETF in the health care sector. What would you consider to be a more favourable alternative that exhibits better growth and some income as well ? Cheers, Tamara
Read Answer Asked by Tamara on July 15, 2019
Q: I'm looking to take advantage of the strengthening CAD and add risk by selling my stake in GUD (break even) and purchasing caredx and gaurdent for a five year holding period. Is this a bad idea? Will recent comments from the White House around healthcare reform help or hurt these companies? Thanks
Read Answer Asked by dan on July 12, 2019
Q: Good morning 5i, I am still plodding along with asset allocator. I have only Weed left in healthcare having sold GUD, and COV. I need 9% so another 7% after WEED. Happy to buy in $US or $Cdn and looking at XHC, IHI, PFE, ZTS. I appreciate your input. Regards, Ted
Read Answer Asked by Ted on July 09, 2019
Q: Good morning team,
Re: Gud's NCIB:
“Be mindful that the largest beneficiary of the share repurchase program is Jonathan Goodman. Even if he does not participate, the reduction of shares at a substantial discount to last $10 per share capital raise only serves to increase his percentage control of the company. Like his conflicting interests with his family business (Pharmascience), either way he wins and shareholders lose.

“Rather than engage in financial engineering that principally benefits the CEO, why didn’t the Board consider a partial tender offer for shares at $10? Just give shareholders their money back at the price paid? It’s a fair question. But one that we fully expect the company to ignore.

https://ca.finance.yahoo.com/news/medison-biotech-jonathan-goodman-takes-124100485.html

Comments please,
Thank you!
Read Answer Asked by Silvia on July 09, 2019
Q: Hi 5i,

Can I get your thoughts on Personalis, Inc.? It has pulled back since the IPO. What do you think of the risk/reward ratio? Would it compare to Guardant?

TIA!
Read Answer Asked by Wayne on July 08, 2019
Q: Does the legal action started have any possibility? Most of these issues end up dying a slow death. Shareholders have been deceived but whether there is sufficient fact here is questionable as is the usual response of the TSX and authorities to simply allow managements actions that are clearly against minority shareholders wishes. It would be nice to see some teeth in investor law.
Read Answer Asked by david on July 08, 2019
Q: Hi 5i team,
Thank you for your answer on Eidos Therapeutic on 21st, June. I own this stock and has gone up 30% + thanks to your positive comment ( at least the ceo has bought 28m in shares), I usually hold on to my winner and let it runs, but I do not understand why it gone up so fast within a short period of time with no news.

As stated in your answer, the company has no revenue and is still losing money. Do you see further upside for this stock ? Should I continue to hold ?

Thank you for your excellent service and helpful advice as always.

Read Answer Asked by Pui on July 05, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!